(Q33768742)

29 July 2017

1 reference

title

Treatment and prevention of multidrug-resistant tuberculosis (English)

1 reference

29 July 2017

0 references

multiple drug resistance

1 reference

multidrug-resistant tuberculosis

inferred from title

1 reference

Bastian I

1

1 reference

29 July 2017

Colebunders R

series ordinal

2

1 reference

29 July 2017

publication date

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

58

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

633-661

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958040-00005

29 July 2017

exact match

0 references

cites work

The clinical use of fluoroquinolones for the treatment of mycobacterial diseases

1 reference

12 December 2020

Tuberculosis preventive therapy in HIV-infected individuals. A Joint Statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lung Disease (IUATLD)

1 reference

12 December 2020

The interest of follow-up of resistance of the tubercle bacillus in the evaluation of a programme

1 reference

12 December 2020

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

1 reference

12 December 2020

In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains

1 reference

12 December 2020

Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes

1 reference

12 December 2020

Trends in drug-resistant tuberculosis in the United States, 1993-1996

1 reference

12 December 2020

Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995.

1 reference

12 December 2020

Global tuberculosis incidence and mortality during 1990-2000.

1 reference

12 December 2020

Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.

1 reference

12 December 2020

Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients

1 reference

12 December 2020

Drug resistance of Mycobacterium tuberculosis in Korea

1 reference

12 December 2020

Drug-resistant tuberculosis in a southern California hospital. Trends from 1969 to 1984.

1 reference

12 December 2020

Streptomycin in the treatment of tuberculosis in humans, meningitis and generalized hematogenous tuberculosis

1 reference

12 December 2020

Clarithromycin is inactive against Mycobacterium tuberculosis

1 reference

12 December 2020

Treatment of multidrug-resistant tuberculosis

1 reference

12 December 2020

Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group

1 reference

12 December 2020

Drug resistant tuberculosis in sub-Saharan Africa: an estimation of incidence and cost for the year 2000.

1 reference

12 December 2020

Rifampin preventive therapy for tuberculosis in Boston's homeless.

1 reference

12 December 2020

Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients.

1 reference

12 December 2020

Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires

1 reference

12 December 2020

Directly observed therapy in New York City. History, implementation, results, and challenges

1 reference

12 December 2020

A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council

1 reference

12 December 2020

Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens

1 reference

12 December 2020

The use of preventive therapy for tuberculous infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis

1 reference

12 December 2020

Drug treatment of tuberculosis--1992

1 reference

12 December 2020

Immunotherapy with Mycobacterium vaccae combined with second line chemotherapy in drug-resistant abdominal tuberculosis.

1 reference

12 December 2020

Metronidazole has no antibacterial effect in Cornell model murine tuberculosis.

1 reference

12 December 2020

Predictors and outcome of multidrug-resistant tuberculosis

1 reference

12 December 2020

Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies

1 reference

12 December 2020

Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

The prevention and management of drug-resistant tuberculosis

1 reference

12 December 2020

Increasing incidence of tuberculosis in England and Wales: a study of the likely causes.

1 reference

12 December 2020

Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration

1 reference

12 December 2020

Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.

1 reference

12 December 2020

Antituberculosis activities of clofazimine and its new analogs B4154 and B4157

1 reference

12 December 2020

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

12 December 2020

Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak

1 reference

12 December 2020

Preventing multidrug-resistant tuberculosis

1 reference

12 December 2020

Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

1 reference

12 December 2020

Quinolones for the treatment and prophylaxis of tuberculosis.

1 reference

12 December 2020

Antituberculosis activity of clarithromycin

1 reference

12 December 2020

Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers

1 reference

12 December 2020

Secular trends of tuberculosis in western Europe.

1 reference

12 December 2020

Compliance with chemotherapy for tuberculosis. Responsibilities of the Health Ministry and of physicians

1 reference

12 December 2020

Preventive therapy for tuberculosis in HIV infection: the promise and the reality

1 reference

12 December 2020

Tuberculosis trends in eastern Europe and the former USSR.

1 reference

12 December 2020

In support of bacillus of Calmette and Guérin for healthcare workers

1 reference

12 December 2020

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy

1 reference

12 December 2020

Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis

1 reference

12 December 2020

In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis

1 reference

12 December 2020

Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

1 reference

12 December 2020

When tuberculosis treatment fails. A social behavioral account of patient adherence

1 reference

12 December 2020

Therapy of multidrug-resistant tuberculosis: lessons from studies with mice

1 reference

12 December 2020

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results

1 reference

12 December 2020

The effect of war on tuberculosis. Results of a tuberculin survey among displaced persons in El Salvador and a review of the literature.

1 reference

12 December 2020

Treatment of tuberculosis by the nonpulmonary physician

1 reference

12 December 2020

Drug resistant tuberculosis in prisons in Azerbaijan: case study

1 reference

12 December 2020

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

1 reference

12 December 2020

Drug-resistant tuberculosis in Korea, 1994

1 reference

12 December 2020

Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

1 reference

12 December 2020

In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

Dormancy of Mycobacterium tuberculosis and latency of disease

1 reference

12 December 2020

The use of high-efficiency particulate air-filter respirators to protect hospital workers from tuberculosis. A cost-effectiveness analysis

1 reference

12 December 2020

Bacille Calmette-Guérin vaccination for the prevention of tuberculosis in health care workers

1 reference

12 December 2020

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

12 December 2020

Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia. Report for the first 4 years of the study (1961-64)

1 reference

12 December 2020

Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention

1 reference

12 December 2020

Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents

1 reference

12 December 2020

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

12 December 2020

In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).

1 reference

12 December 2020

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease

1 reference

12 December 2020

Drug-resistant tuberculosis

1 reference

12 December 2020

Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview

1 reference

12 December 2020

Assessment of worldwide tuberculosis control

1 reference

12 December 2020

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

1 reference

12 December 2020

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

12 December 2020

Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers

1 reference

12 December 2020

Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis

1 reference

12 December 2020

The resurgence of tuberculosis: is your laboratory ready?

1 reference

12 December 2020

Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis

1 reference

12 December 2020

Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis

1 reference

12 December 2020

Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections.

1 reference

12 December 2020

Chemoprophylaxis of multidrug-resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide. A decision analysis

1 reference

12 December 2020

Tuberculosis in New York City--turning the tide

1 reference

12 December 2020

Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment

1 reference

12 December 2020

Outbreak of multidrug-resistant tuberculosis--Texas, California, and Pennsylvania

1 reference

12 December 2020

Resistant tuberculosis: successful treatment with amikacin, ofloxacin, clofazimine, and pas.

1 reference

12 December 2020

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

1 reference

12 December 2020

Emergence of fluoroquinolone-resistant tuberculosis in New York City.

1 reference

12 December 2020

Pharmacology of the antimycobacterial drugs.

1 reference

12 December 2020

Epidemiology of tuberculosis in the United States, 1985 through 1992.

1 reference

12 December 2020

Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique

1 reference

12 December 2020

Clinical experience with rifabutin in the treatment of mycobacterial infections

1 reference

12 December 2020

Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance

1 reference

12 December 2020

In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis

1 reference

12 December 2020

Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis

1 reference

12 December 2020

The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis

1 reference

12 December 2020

Institutional control measures for tuberculosis in the era of multiple drug resistance. ACCP/ATS Consensus Conference. American College of Chest Physicians and the American Thoracic Society

1 reference

12 December 2020

Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis

1 reference

12 December 2020

Do beta-lactam-beta-lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis?

1 reference

12 December 2020

Tuberculosis and poverty

1 reference

12 December 2020

The cost of tuberculosis to patients in Sierra Leone's war zone.

1 reference

12 December 2020

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis

1 reference

12 December 2020

Current practices in mycobacteriology: results of a survey of state public health laboratories

1 reference

12 December 2020

Short-course chemotherapy of tuberculosis. Hail Britannia (and friends)!

1 reference

12 December 2020

The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infections: a community-based study

1 reference

12 December 2020

Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance

1 reference

12 December 2020

1 reference

12 December 2020

Bacille Calmette Guérin immunization of health care workers exposed to multidrug-resistant tuberculosis: a decision analysis

1 reference

12 December 2020

Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries

1 reference

12 December 2020

Use of rifabutin in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.

1 reference

12 December 2020

Multidrug-resistant tuberculosis in patients without HIV infection

1 reference

12 December 2020

The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices

1 reference

12 December 2020

Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

1 reference

12 December 2020

Tuberculosis in developing countries: burden, intervention and cost

1 reference

12 December 2020

Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care facilities, 1994

1 reference

12 December 2020

Activity of amoxicillin/clavulanate in patients with tuberculosis

1 reference

12 December 2020

Eleven years of community-based directly observed therapy for tuberculosis

1 reference

12 December 2020

A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes

1 reference

12 December 2020

Outbreak of hospital acquired multidrug resistant tuberculosis

1 reference

12 December 2020

Management of persons exposed to multidrug-resistant tuberculosis

1 reference

12 December 2020

Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.

1 reference

12 December 2020

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

1 reference

12 December 2020

Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City

1 reference

12 December 2020

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

1 reference

12 December 2020

Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis.

1 reference

12 December 2020

Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey

1 reference

12 December 2020

Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance?

1 reference

12 December 2020

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic

1 reference

12 December 2020

Sputum smear conversion during directly observed treatment for tuberculosis

1 reference

12 December 2020

How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis

1 reference

12 December 2020

Inhibitors of branched-chain amino acid biosynthesis as potential antituberculosis agents

1 reference

12 December 2020

Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century

1 reference

12 December 2020

Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin

1 reference

12 December 2020

In-vitro activities of quinolones against mycobacteria

1 reference

12 December 2020

Development of a suicide gene as a novel approach to killing Mycobacterium tuberculosis

1 reference

12 December 2020

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

12 December 2020

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

12 December 2020

Multidrug-resistant tuberculosis: prevention is better than cure

1 reference

12 December 2020

Profiles of non-compliance with antituberculous therapy.

1 reference

12 December 2020

Preventing the nosocomial transmission of tuberculosis

1 reference

12 December 2020

Surgery in the treatment of multidrug-resistant tuberculosis

1 reference

12 December 2020

New tuberculosis drug development. How can we do better?

1 reference

12 December 2020

Malabsorption of antituberculosis medications by a patient with AIDS

1 reference

12 December 2020

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs

1 reference

12 December 2020

Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis

1 reference

12 December 2020

Nationwide survey of drug-resistant tuberculosis in the United States.

1 reference

12 December 2020

Multidrug-resistant tuberculosis and its control

1 reference

12 December 2020

The influence of epidemiologic factors on drug resistance rates in tuberculosis

1 reference

12 December 2020

Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991

1 reference

12 December 2020

An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group

1 reference

12 December 2020

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

12 December 2020

10.2165/00003495-199958040-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1051195290

0 references

1 reference